Cancer Profiling Market - Global Industry Analysis

Cancer Profiling Market by Technique (Genomics, Proteomics, Metabolomics, and Epigenetics), by Technology (Immunoassay, Hybridization, Next-Generation Sequencing, Mass Spectroscopy, and Others), by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), and by Application (Personalized Cancer Medicine, Oncological Diagnostics, Research, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 05-Apr-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3997 Status : Published

Global cancer profiling market expected to generate around USD 16.6 billion by 2025, at a CAGR of around 9.9% between 2019 and 2025. The uncontrolled growth of cells due to the defect in the process of cell growth cycle leads to cancer. Cancer may be malignant or benign.

Description

The report covers a forecast and an analysis of the cancer profiling market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the cancer profiling market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cancer profiling market on a global level.

In order to give the users of this report a comprehensive view of the cancer profiling market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Cancer Profiling Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new assay kits launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.

The study provides a decisive view of the cancer profiling market on the basis of technique, technology, cancer type, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some key players of the global cancer profiling market are HTG Molecular Diagnostic, Illumina, NeoGenomics Laboratories, QIAGEN, Caris Life Sciences, Helomics Corporation, Oxford Gene Technology, Genomic Health, NanoString Technologies, and RiboMed Biotechnologies.

This report segments the global cancer profiling market as follows:

Global Cancer Profiling Market: Technique Analysis

  • Genomics
  • Proteomics
  • Metabolomics
  • Epigenetics

Global Cancer Profiling Market: Technology Analysis

  • Immunoassay
  • Hybridization
  • Next-Generation Sequencing
  • Mass Spectroscopy
  • Others

Global Cancer Profiling Market: Cancer Type Analysis

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Melanoma Cancer
  • Others

Global Cancer Profiling Market: Application Analysis

  • Personalized Cancer Medicine
  • Oncological Diagnostics
  • Research
  • Others

Global Cancer Profiling Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global cancer profiling market, 2016-2025 (USD Billion)
    • 2.2. Global cancer profiling market: Snapshot
  •  
  • Chapter 3. Cancer Profiling Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global cancer profiling market drivers: Impact analysis
      • 3.2.2. Increasing Number of New Cancer Cases
      • 3.2.3. Increasing Utility of Biomarkers in Tumor Profiling
      • 3.2.4. Availability of Funding for Cancer Research
    • 3.3. Market Restraints
      • 3.3.1. Global cancer profiling market restraints: Impact analysis
      • 3.3.2. High Capital Investments and Low Benefit Ratio for Biomarkers
      • 3.3.3. Lack of Skilled Professionals and Infrastructure
    • 3.4. Opportunities
      • 3.4.1. Point-Of-Care Diagnostic Tests
      • 3.4.2. Increasing Demand for Personalized Medicine
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by technique
      • 3.6.2. Market attractiveness analysis, by technology
      • 3.6.3. Market attractiveness analysis, by cancer type
      • 3.6.4. Market attractiveness analysis, by application
      • 3.6.5. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Cancer Profiling Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global cancer profiling market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New instruments launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Cancer Profiling Market - Technique Analysis
    • 5.1. Global cancer profiling market: Technique overview
      • 5.1.1. Global cancer profiling market revenue share, by technique, 2018 and 2025
    • 5.2. Genomics
      • 5.2.1. Global cancer profiling market for genomics, 2016-2025 (USD Billion)
    • 5.3. Proteomics
      • 5.3.1. Global cancer profiling market for proteomics, 2016-2025 (USD Billion)
    • 5.4. Metabolomics
      • 5.4.1. Global cancer profiling market for metabolomics, 2016-2025 (USD Billion)
    • 5.5. Epigenetics
      • 5.5.1. Global cancer profiling market for epigenetics, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Cancer Profiling Market - Technology Analysis
    • 6.1. Global cancer profiling market: Technology overview
      • 6.1.1. Global cancer profiling market revenue share, by technology, 2018 and 2025
    • 6.2. Immunoassays
      • 6.2.1. Global cancer profiling market for immunoassays, 2016-2025 (USD Billion)
    • 6.3. Hybridization
      • 6.3.1. Global cancer profiling market for hybridization, 2016-2025 (USD Billion)
    • 6.4. Next-Generation Sequencing
      • 6.4.1. Global cancer profiling market for Next-Generation sequencing, 2016-2025 (USD Billion)
    • 6.5. Mass Spectroscopy
      • 6.5.1. Global cancer profiling market for mass spectroscopy, 2016-2025 (USD Billion)
    • 6.6. Others
      • 6.6.1. Global cancer profiling market for others, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Cancer Profiling Market - Cancer Type Analysis
    • 7.1. Global cancer profiling market: Cancer Type overview
      • 7.1.1. Global cancer profiling market revenue share, by cancer type, 2018 and 2025
    • 7.2. Colorectal Cancer
      • 7.2.1. Global cancer profiling market for colorectal cancer, 2016-2025 (USD Billion)
    • 7.3. Prostate Cancer
      • 7.3.1. Global cancer profiling market for prostate cancer, 2016-2025 (USD Billion)
    • 7.4. Breast Cancer
      • 7.4.1. Global cancer profiling market for breast cancer, 2016-2025 (USD Billion)
    • 7.5. Lung Cancer
      • 7.5.1. Global cancer profiling market for lung cancer, 2016-2025 (USD Billion)
    • 7.6. Melanoma Cancer
      • 7.6.1. Global cancer profiling market for melanoma cancer, 2016-2025 (USD Billion)
    • 7.7. Others
      • 7.7.1. Global cancer profiling market for others, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global Cancer Profiling Market - Application Analysis
    • 8.1. Global cancer profiling market: Application overview
      • 8.1.1. Global cancer profiling market revenue share, by application, 2018 and 2025
    • 8.2. Personalized Cancer Medicine
      • 8.2.1. Global cancer profiling market for personalized cancer medicine, 2016-2025 (USD Billion)
    • 8.3. Oncological Diagnostics
      • 8.3.1. Global cancer profiling market for oncological diagnostics, 2016-2025 (USD Billion)
    • 8.4. Research
      • 8.4.1. Global cancer profiling market for research, 2016-2025 (USD Billion)
    • 8.5. Others
      • 8.5.1. Global cancer profiling market for others, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Global Cancer Profiling Market - Regional Analysis
    • 9.1. Global cancer profiling market: Regional overview
      • 9.1.1. Global cancer profiling market revenue share, by region, 2018 and 2025
    • 9.2. North America
      • 9.2.1. North America cancer profiling market, 2016-2025 (USD Billion)
      • 9.2.2. North America cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
      • 9.2.3. North America cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
      • 9.2.4. North America cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
      • 9.2.5. North America cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.2.6. The U.S.
        • 9.2.6.1. The U.S. cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.2.6.2. The U.S. cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.2.6.3. The U.S. cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.2.6.4. The U.S. cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.2.7. Canada
        • 9.2.7.1. Canada cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.2.7.2. Canada cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.2.7.3. Canada cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.2.7.4. Canada cancer profiling market revenue, by application, 2016-2025 (USD Billion)
    • 9.3. Europe
      • 9.3.1. Europe cancer profiling market, 2016-2025 (USD Billion)
      • 9.3.2. Europe cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
      • 9.3.3. Europe cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
      • 9.3.4. Europe cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
      • 9.3.5. Europe cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.3.6. UK
        • 9.3.6.1. UK cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.3.6.2. UK cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.3.6.3. UK cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.3.6.4. UK cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.3.7. Germany
        • 9.3.7.1. Germany cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.3.7.2. Germany cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.3.7.3. Germany cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.3.7.4. Germany cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.3.8. France
        • 9.3.8.1. France cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.3.8.2. France cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.3.8.3. France cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.3.8.4. France cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.3.9. Rest of Europe
        • 9.3.9.1. Rest of Europe cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.3.9.2. Rest of Europe cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.3.9.3. Rest of Europe cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.3.9.4. Rest of Europe cancer profiling market revenue, by application, 2016-2025 (USD Billion)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific cancer profiling market, 2016-2025 (USD Billion)
      • 9.4.2. Asia Pacific cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
      • 9.4.3. Asia Pacific cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
      • 9.4.4. Asia Pacific cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
      • 9.4.5. Asia Pacific cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.4.6. China
        • 9.4.6.1. China cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.4.6.2. China cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.4.6.3. China cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.4.6.4. China cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.4.7. Japan
        • 9.4.7.1. Japan cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.4.7.2. Japan cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.4.7.3. Japan cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.4.7.4. Japan cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.4.8. India
        • 9.4.8.1. India cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.4.8.2. India cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.4.8.3. India cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.4.8.4. India cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.4.9. Rest of Asia Pacific
        • 9.4.9.1. Rest of Asia Pacific cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.4.9.2. Rest of Asia Pacific cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.4.9.3. Rest of Asia Pacific cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.4.9.4. Rest of Asia Pacific cancer profiling market revenue, by application, 2016-2025 (USD Billion)
    • 9.5. Latin America
      • 9.5.1. Latin America cancer profiling market, 2016-2025 (USD Billion)
      • 9.5.2. Latin America cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
      • 9.5.3. Latin America cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
      • 9.5.4. Latin America cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
      • 9.5.5. Latin America cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.5.6. Brazil
        • 9.5.6.1. Brazil cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.5.6.2. Brazil cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.5.6.3. Brazil cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.5.6.4. Brazil cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.5.7. Rest of Latin America
        • 9.5.7.1. Rest of Latin America cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.5.7.2. Rest of Latin America cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.5.7.3. Rest of Latin America cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.5.7.4. Rest of Latin America cancer profiling market revenue, by application, 2016-2025 (USD Billion)
    • 9.6. The Middle East and Africa
      • 9.6.1. The Middle East and Africa cancer profiling market, 2016-2025 (USD Billion)
      • 9.6.2. The Middle East and Africa cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
      • 9.6.3. The Middle East and Africa cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
      • 9.6.4. The Middle East and Africa cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
      • 9.6.5. The Middle East and Africa cancer profiling market revenue, by application, 2016-2025 (USD Billion)
  •  
  • Chapter 10. Company Profile
    • 10.1. Illumina
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product Portfolio
      • 10.1.4. Business Strategy
      • 10.1.5. Recent Developments
    • 10.2. QIAGEN
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product Portfolio
      • 10.2.4. Business Strategy
      • 10.2.5. Recent Developments
    • 10.3. NeoGenomics Laboratories
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product Portfolio
      • 10.3.4. Business Strategy
      • 10.3.5. Recent Developments
    • 10.4. HTG Molecular Diagnostics
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product Portfolio
      • 10.4.4. Business Strategy
      • 10.4.5. Recent Developments
    • 10.5. Genomic Health
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product Portfolio
      • 10.5.4. Business Strategy
      • 10.5.5. Recent Developments
    • 10.6. Caris Life Sciences
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product Portfolio
      • 10.6.4. Business Strategy
      • 10.6.5. Recent Developments
    • 10.7. Helomics Corporation
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product Portfolio
      • 10.7.4. Business Strategy
      • 10.7.5. Recent Developments
    • 10.8. NanoString Technologies
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product Portfolio
      • 10.8.4. Business Strategy
      • 10.8.5. Recent Developments
    • 10.9. Oxford Gene Technologies
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product Portfolio
      • 10.9.4. Business Strategy
      • 10.9.5. Recent Developments
    • 10.10. RiboMed Biotechnologies
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product Portfolio
      • 10.10.4. Business Strategy
      • 10.10.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global cancer profiling market revenue, 2016–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Cancer Profiling market attractiveness analysis, by technique
6. Cancer Profiling market attractiveness analysis, by technology
7. Cancer Profiling market attractiveness analysis, by cancer type
8. Cancer Profiling market attractiveness analysis, by application
9. Cancer Profiling market: market attractiveness analysis, by region
10. Company market share analysis, 2018
11. Global cancer profiling market revenue share by technique, 2018 and 2025
12. Global cancer profiling market for genomics, 2016–2025 (USD Billion)
13. Global cancer profiling market for proteomics, 2016–2025 (USD Billion)
14. Global cancer profiling market for metabolomics, 2016–2025 (USD Billion)
15. Global cancer profiling market for epigenetics, 2016–2025 (USD Billion)
16. Global cancer profiling market revenue share by technology, 2018 and 2025
17. Global cancer profiling market for immunoassays, 2016–2025 (USD Billion)
18. Global cancer profiling market for hybridization, 2016–2025 (USD Billion)
19. Global cancer profiling market for Next-Generation sequencing, 2016–2025 (USD Billion)
20. Global cancer profiling market for mass spectroscopy, 2016–2025 (USD Billion)
21. Global cancer profiling market for others, 2016–2025 (USD Billion)
22. Global cancer profiling market revenue share by cancer type, 2018 and 2025
23. Global cancer profiling market for breast cancer, 2016–2025 (USD Billion)
24. Global cancer profiling market for lung cancer, 2016–2025 (USD Billion)
25. Global cancer profiling market for prostate cancer, 2016–2025 (USD Billion)
26. Global cancer profiling market for colorectal cancer, 2016–2025 (USD Billion)
27. Global cancer profiling market for melanoma cancer, 2016–2025 (USD Billion)
28. Global cancer profiling market for others, 2016–2025 (USD Billion)
29. Global cancer profiling market revenue share by application, 2018 and 2025
30. Global cancer profiling market for personalized cancer medicine, 2016–2025 (USD Billion)
31. Global cancer profiling market for oncological diagnostics, 2016–2025 (USD Billion)
32. Global cancer profiling market for research, 2016–2025 (USD Billion)
33. Global cancer profiling market for others, 2016–2025 (USD Billion)
34. North America cancer profiling market, 2016–2025 (USD Billion)
35. Europe cancer profiling market, 2016–2025 (USD Billion)
36. Asia Pacific cancer profiling market, 2016–2025 (USD Billion)
37. Latin America cancer profiling market, 2016–2025 (USD Billion)
38. The Middle East and Africa cancer profiling market, 2016–2025 (USD Billion)


Table Of Tables

List of Tables

1. Global cancer profiling market: Market Snapshot                                                                                                                        
2. Drivers of global cancer profiling market: Impact analysis 
3. Restraints of global cancer profiling market: Impact analysis  
4. North America cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
5. North America cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
6. North America cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
7. North America cancer profiling market revenue, by application, 2016–2025 (USD Billion)
8. The U.S. cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
9. The U.S. cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
10. The U.S. cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
11. The U.S. cancer profiling market revenue, by application, 2016–2025 (USD Billion)
12. Canada cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
13. Canada cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
14. Canada cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
15. Canada cancer profiling market revenue, by application, 2016–2025 (USD Billion)
16. Europe cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
17. Europe cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
18. Europe cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
19. Europe cancer profiling market revenue, by application, 2016–2025 (USD Billion)
20. UK cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
21. UK cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
22. UK cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
23. UK cancer profiling market revenue, by application, 2016–2025 (USD Billion)
24. Germany cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
25. Germany cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
26. Germany cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
27. Germany cancer profiling market revenue, by application, 2016–2025 (USD Billion)
28. France cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
29. France cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
30. France cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
31. France cancer profiling market revenue, by application, 2016–2025 (USD Billion)
32. Rest of Europe cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
33. Rest of Europe cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
34. Rest of Europe cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
35. Rest of Europe cancer profiling market revenue, by application, 2016–2025 (USD Billion)
36. Asia Pacific cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
37. Asia Pacific cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
38. Asia Pacific cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
39. Asia Pacific cancer profiling market revenue, by application, 2016–2025 (USD Billion)
40. China cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
41. China cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
42. China cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
43. China cancer profiling market revenue, by application, 2016–2025 (USD Billion)
44. Japan cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
45. Japan cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
46. Japan cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
47. Japan cancer profiling market revenue, by application, 2016–2025 (USD Billion)
48. India cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
49. India cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
50. India cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
51. India cancer profiling market revenue, by application, 2016–2025 (USD Billion)
52. Rest of Asia Pacific cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
53. Rest of Asia Pacific cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
54. Rest of Asia Pacific cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
55. Rest of Asia Pacific cancer profiling market revenue, by application, 2016–2025 (USD Billion)
56. Latin America cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
57. Latin America cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
58. Latin America cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
59. Latin America cancer profiling market revenue, by application, 2016–2025 (USD Billion)
60. Brazil cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
61. Brazil cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
62. Brazil cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
63. Brazil cancer profiling market revenue, by application, 2016–2025 (USD Billion)
64. Rest of Latin America cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
65. Rest of Latin America cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
66. Rest of Latin America cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
67. Rest of Latin America cancer profiling market revenue, by application, 2016–2025 (USD Billion)
68. The Middle East and Africa cancer profiling market revenue, by technique, 2016–2025 (USD Billion)
69. The Middle East and Africa cancer profiling market revenue, by technology, 2016–2025 (USD Billion)
70. The Middle East and Africa cancer profiling market revenue, by cancer type, 2016–2025 (USD Billion)
71. The Middle East and Africa cancer profiling market revenue, by application, 2016–2025 (USD Billion)

Methodology

Free Analysis

Cancer profiling is a technique used as a diagnostic test to detect cancer genetically. This test provides genetic information stored inside cancer or tumor cells. This technique helps in determining the correct action course alongside assisting the doctor to zero on the exact therapeutics needed by the patient, which, in turn, increases the efficacy of the treatment.

According to the WHO (World Health Organization), cancer is the second leading cause of death worldwide. Additionally, it was estimated that about 9.6 million deaths occurred globally in 2018 due to cancer. According to the Cancer Research UK, about 17 million new cancer cases were registered globally in 2018. The globally growing prevalence of cancer is mainly anticipated to drive the growth of the global cancer profiling market. The rise in the adoption of cancer biomarkers for cancer profiling, increase in the number of research activities for cancer treatments, development of various cancer diagnostics techniques, and growth in investments made by governments and other institutions for cancer research and demand for personalized medicines in developed countries are driving the global cancer profiling market. The growing awareness about cancer profiling techniques and increase in efforts by companies to launch new technologies for cancer profiling are also fueling the global market for cancer profiling. However, the dearth of skilled professionals and infrastructure in developing countries may hamper the global cancer profiling market in the future.

Global Cancer Profiling Market

The global cancer profiling market is divided into technique, technology, cancer type, and application. By technique, the market for cancer profiling includes genomics, epigenetics, proteomics, and metabolomics. Genomics dominated the cancer profiling market in 2018, owing to its cost-effectiveness and improved screen time. Based on technology, the cancer profiling market includes in situ hybridization, PCR, immunohistochemistry, microarray, next-generation sequencing, and others. By cancer type, the cancer profiling market includes prostate cancer, melanoma cancer, breast cancer, colorectal cancer, lung cancer, and others. The growing prevalence of breast cancer among women is mainly fueling the breast cancer segment. Based on application, the cancer profiling market includes personalized medicine, oncological diagnostics, research, and others. Personalized medicine is anticipated to show high growth in the future, due to the growing awareness about the advantages of personalized medicines in developed countries and the rising number of research and development activities for personalized medicine.

By region, North America dominated the global market in 2018 owing to high cancer prevalence, developed healthcare infrastructure, and an increase in the number of cancer-related research activities. Asia Pacific is expected to show the highest CAGR in the upcoming years, owing to the growing cancer prevalence in developing countries like India and China, rising investments by companies and governments in cancer research, and increasing awareness about cancer profiling techniques.

Some key players of the global cancer profiling market are HTG Molecular Diagnostic, Illumina, NeoGenomics Laboratories, QIAGEN, Caris Life Sciences, Helomics Corporation, Oxford Gene Technology, Genomic Health, NanoString Technologies, and RiboMed Biotechnologies.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed